Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

HK Type 4 license through Ballingal Investment Advisors Ltd. 

I'm a highly experienced sell-side analyst with in excess of 22 years of covering Asia Pacific equities, the past 19 years immersed in event strategies encompassing M&A risk arbitrage, directional long/short, stub trades and restructuring.  

My background also includes accountancy (liquidation/bankruptcy/receivership) earlier in my career and as a chief financial officer of a global commodity company based in the US and Mexico.

Pan-Asia Catalysts/Events

ANE (9956 HK): Pre-Cons Satisfied. Possible Payment Early March

ANE Cayman (9956 HK): On S329 Reports And Letters Of Interest

Quiddity Advisors

Event-Driven

<ul>
<li>The feedback I get on this transaction canvasses comments such as: "it just doesn't feel right", or "there's something funny going on", or simply "weird". </li>
<li>With~20% of the shareholder register, involving opaque pre-IPO investors, none of whom have provided IUs, a <a href="https://www.smartkarma.com/entities/shanghai-henlius-biotech-inc" target="_blank" data-smartkarma-citation="entities:27888:1" rel="noopener">Shanghai Henlius (2696 HK)</a>-like situation unfolding is bandied around. The comparison is, however, tenuous.</li>
<li>Further inquiries suggest CDH is likely in control of 18% of that 20%. This needs to be clarified.</li>
</ul>


The feedback I get on this transaction canvasses comments such as: "it just doesn't feel right", or "there's something funny going on", or simply "weird". 
With~20% of the shareholder register, involving opaque pre-IPO investors, none of whom have provided IUs, a Shanghai Henlius (2696 HK)-like situation unfolding is bandied around. The comparison is, however, tenuous.
Further inquiries suggest CDH is likely in control of 18% of that 20%. This needs to be clarified.


ANE Cayman (9956 HK): CDH Holds All The Cards

ANE Cayman Inc

ANE Cayman (9956 HK): CDH Holds All The Cards